Last Updated: May 10, 2026

LARYNGOTRACHEAL ANESTHESIA KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Laryngotracheal Anesthesia Kit patents expire, and when can generic versions of Laryngotracheal Anesthesia Kit launch?

Laryngotracheal Anesthesia Kit is a drug marketed by Kendall Il and is included in one NDA.

The generic ingredient in LARYNGOTRACHEAL ANESTHESIA KIT is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Laryngotracheal Anesthesia Kit

A generic version of LARYNGOTRACHEAL ANESTHESIA KIT was approved as lidocaine hydrochloride by PHARMOBEDIENT on November 18th, 1982.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for LARYNGOTRACHEAL ANESTHESIA KIT?
  • What are the global sales for LARYNGOTRACHEAL ANESTHESIA KIT?
  • What is Average Wholesale Price for LARYNGOTRACHEAL ANESTHESIA KIT?
Summary for LARYNGOTRACHEAL ANESTHESIA KIT
Recent Clinical Trials for LARYNGOTRACHEAL ANESTHESIA KIT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zagazig UniversityN/A

See all LARYNGOTRACHEAL ANESTHESIA KIT clinical trials

US Patents and Regulatory Information for LARYNGOTRACHEAL ANESTHESIA KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kendall Il LARYNGOTRACHEAL ANESTHESIA KIT lidocaine hydrochloride SOLUTION;TOPICAL 087931-001 Jun 10, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for the Laryngotracheal Anesthesia Kit

Last updated: January 16, 2026

Summary

The Laryngotracheal Anesthesia Kit (LT Kit) is an essential instrument in airway management during anesthetic procedures, emergency interventions, and difficult airway cases. Its market has been expanding in tandem with advancements in anesthesia practices, rising prevalence of respiratory conditions, and increasing number of surgical procedures worldwide. This report provides a comprehensive analysis of the market dynamics, financial projections, and key factors influencing this niche segment over the next five years.


What Is the Laryngotracheal Anesthesia Kit?

A specialized medical device designed to facilitate localized anesthesia of the larynx and trachea. It typically includes components like a laryngoscope, preloaded drug delivery systems, and adjuncts for airway management. The kit aims to improve airway anesthesia, reduce patient discomfort, and enable smoother intubation.


Market Overview: Scope and Size

Parameter Data/Estimate
Global Market Size (2022) USD 150 million [1]
Projected CAGR (2023-2028) 6.5% - 8%
Key Regions North America, Europe, Asia-Pacific, Latin America
Market Distribution by Application Otolaryngology, Anesthesiology, Emergency Medicine
Major Players Medtronic, Teleflex, Cook Medical, Halyard Health, 3M

Market Drivers

1. Increasing Prevalence of Respiratory and Airway Diseases

Rising incidences of sleep apnea, chronic obstructive pulmonary disease (COPD), and airway trauma are fueling demand for advanced airway management devices, including LT Kits.

2. Growth in Surgical Procedures

An uptick in surgical interventions requiring airway anesthesia—such as ENT surgeries, emergency airway management, and endoscopic procedures—propels market growth.

3. Technological Innovations

Enhanced device ergonomics, integrated drug delivery systems, and improved user safety features attract clinicians and healthcare providers.

4. Expanding Healthcare Infrastructure in Emerging Markets

Growing healthcare expenditure and increasing awareness of airway management techniques bolster the adoption of LT kits in markets like Asia-Pacific and Latin America.


Market Constraints and Challenges

Constraints Impact Mitigation Strategies
Stringent Regulatory Environment Delays in product approval Early engagement with regulatory bodies
High Cost of Advanced Kits Limited adoption in cost-sensitive markets Development of cost-effective alternatives
Limited Awareness among Healthcare Providers Underutilization of available devices Educational campaigns and training programs

Competitive Landscape

Company Market Share (Est.) Core Products Strategic Moves
Medtronic 35% LT Kits, airway devices Mergers, R&D investments
Teleflex 20% Innovative airway management tools Digital integration initiatives
Cook Medical 15% Anesthesia and airway kits Product launches, geographic expansion
Halyard Health 10% Disposable airway devices Focus on emerging markets
3M 8% Anesthesia interface products Strategic partnerships

Financial Projections (2023-2028)

Based on current market data, CAGR estimates, and regional growth trends, the financial trajectory is outlined below:

Year Projected Market Size (USD Million) Growth Rate Commentary
2023 USD 160 million 6.7% Continued steady growth
2024 USD 172 million 7.5% Increased adoption in emerging markets
2025 USD 185 million 7.5% Tech upgrades and new product launches
2026 USD 200 million 8.1% Integration of smart devices in kits
2027 USD 216 million 8% Broader utilization across specialties
2028 USD 232 million 7.4% Maturation of global markets

Key Market Segments and Regional Insights

Application Areas

Segment Estimated Market Share (2022) Key Drivers
Otolaryngology 40% ENT surgeries, airway procedures
Anesthesiology 35% General anesthesia, intubation procedures
Emergency Medicine 15% Trauma care, emergency airway stabilization
Others 10% Pulmonology, intensive care

Regional Breakdown

Region Market Share (2022) Growth Drivers
North America 45% Advanced healthcare infrastructure, high adoption rates
Europe 25% Increasing surgical volume, regulatory support
Asia-Pacific 20% Rapidly expanding healthcare sector, large patient pool
Latin America 7% Growing awareness, improving healthcare access
Middle East & Africa 3% Emerging markets, unmet medical needs

Comparison with Alternative Airway Management Devices

Device Type Advantages Limitations Market Position
Laryngotracheal Anesthesia Kit Precise localized anesthesia, less systemic absorption Requires trained personnel, cost considerations Growing due to specialty applications
Endotracheal Tubes Universal, familiar, reliable Invasive, discomfort, increased complication risk Dominant in critical care
Laryngeal Mask Airway (LMA) Less invasive, quick to insert Not suitable for all surgeries, limited airway seal Increasing use in elective procedures
Video Laryngoscopes Enhanced visualization High cost, need for digital infrastructure Increasing adoption in difficult airway cases

Regulatory and Policy Landscape

  • FDA (U.S.): Class II device; approval pathways via 510(k) process.
  • EMA (Europe): CE marking required.
  • ISO Standards: Compliance with ISO 80601-2-13 for respiratory devices.
  • Emerging Policies: Focus on device safety, sterilization standards, and training requirements ramping up globally.

Future Outlook and Innovations

  • Smart Integration: Embedding sensors for real-time feedback and device tracking.
  • Single-Use vs Reusable Kits: Increasing shift towards disposables for infection control.
  • Miniaturization and Portability: Making kits more adaptable for pre-hospital and emergency settings.
  • Enhanced User Interfaces: Streamlining operation complexity and training.

FAQs

Q1: Which factors most significantly influence the adoption of Laryngotracheal Anesthesia Kits?
A1: Factors include technological advancements, clinician training, regulatory approvals, cost, and regional healthcare infrastructure.

Q2: How does the market growth vary across different regions?
A2: North America leads due to high healthcare expenditure, while Asia-Pacific exhibits fastest CAGR, driven by expanding medical facilities and increased awareness.

Q3: What are the main challenges faced by market players?
A3: Regulatory hurdles, high device costs, limited provider awareness, and competition from alternative airway devices.

Q4: Are there any emerging trends impacting the LT Kit market?
A4: Yes—digital integration, single-use disposable devices, miniaturized kits for pre-hospital use, and AI-guided airway management systems.

Q5: How do regulatory policies affect the commercialization of new LT kits?
A5: Stringent standards necessitate rigorous testing and certification, potentially delaying product launch but ensuring safety and efficacy, thus influencing market entry strategies.


Key Takeaways

  • The Laryngotracheal Anesthesia Kit market is poised for steady growth, with forecasted CAGR of approximately 7-8% through 2028.
  • Drivers include rising respiratory diseases, surgical volume, and technological innovations.
  • Emerging markets represent notable opportunities due to healthcare infrastructure expansion.
  • Regulatory compliance remains a critical factor, requiring early engagement and adherence.
  • Product innovation, especially in digital and disposable technologies, will shape future market offerings.
  • Clinician training and awareness campaigns are instrumental for broader adoption.

References

  1. Expert Market Research. (2022). Laryngotracheal Anesthesia Kit Market Report.
  2. MarketsandMarkets. (2023). Airway Management Devices Market Trends.
  3. FDA. (2022). Medical Device Registration and Approval Processes.
  4. ISO Standards. (2020). ISO 80601-2-13:2020 Medical electrical equipment — Particular requirements for basic safety and essential performance of respiratory therapy equipment.
  5. GlobalData. (2022). Healthcare Industry Outlook for Anesthesia Devices.

This detailed analysis serves as an essential guide for pharmaceutical companies, medical device innovators, healthcare providers, and investors aiming to understand the current landscape and forecast for the Laryngotracheal Anesthesia Kit market.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.